1998), and the current presence of immunoglobulins in PD brain tissue may lead to the targeting of dopaminergic nigral neurons for devastation (Orr et al. PD. Multi-epitopic AAb against -synuclein
ROCK inhibitors
1998), and the current presence of immunoglobulins in PD brain tissue may lead to the targeting of dopaminergic nigral neurons for devastation (Orr et al. PD. Multi-epitopic AAb against -synuclein